A 72-year-old man with a 5-year history of benign prostatic hyperplasia presents with acute urinary retention. He has been on tamsulosin 0.4 mg daily for 3 years with good symptom control. Three days ago, he started taking over-the-counter cold medicine containing pseudoephedrine for seasonal rhinitis. He now cannot void and has suprapubic pain and distension. Post-void residual catheterization yields 650 mL of urine. Prostate on DRE is smooth and enlarged. Serum creatinine is 1.8 mg/dL (baseline 1.0 mg/dL). What is the most appropriate immediate management?

Explanation

## Clinical Scenario: Acute Urinary Retention in BPH ### Diagnosis This patient has **acute urinary retention (AUR)** precipitated by a **sympathomimetic agent (pseudoephedrine)** in a patient with pre-existing BPH. **Key Point:** Acute urinary retention is a medical emergency requiring **immediate decompression** to prevent: - Bladder overdistension and decompensation - Upper urinary tract obstruction and acute kidney injury (evidenced by rising creatinine: 1.0 → 1.8 mg/dL) - Urinary tract infection - Permanent bladder dysfunction ### Pathophysiology of Pseudoephedrine-Induced AUR Pseudoephedrine is an **indirect-acting sympathomimetic amine** that: 1. Increases norepinephrine release at α~1~-adrenergic receptors in the prostatic urethra 2. Causes unopposed smooth muscle contraction in a patient already on α-blocker therapy (tamsulosin was masking obstruction) 3. Precipitates acute outlet obstruction and complete urinary retention **Clinical Pearl:** Common precipitants of AUR in BPH patients include: - Sympathomimetics (pseudoephedrine, phenylephrine, ephedrine) - Anticholinergics (antihistamines, tricyclic antidepressants, oxybutynin) - Opioids (reduce detrusor contractility) - Acute infection or inflammation - Large fluid intake or prolonged immobility ### Immediate Management Algorithm ```mermaid flowchart TD A[Acute Urinary Retention]:::urgent --> B[Immediate catheterization]:::action B --> C{Urethral or suprapubic?}:::decision C -->|First attempt: no contraindications| D[Transurethral catheterization]:::action C -->|Failed urethral catheterization| E[Suprapubic catheterization]:::action C -->|Severe urethral trauma/stricture| E D --> F[Drain urine gradually]:::action E --> F F --> G[Investigate precipitant]:::action G --> H[Remove offending agent]:::action H --> I[Trial of void after 24-48 hrs]:::decision I -->|Success| J[Discharge with alpha-blocker]:::outcome I -->|Failure| K[Definitive surgery: TURP/open prostatectomy]:::action ``` **High-Yield:** The **immediate step** is **catheterization (urethral or suprapubic)**, not medical management or surgery. This decompresses the bladder and prevents further renal damage. ### Why Immediate Catheterization? | Reason | Mechanism | |--------|----------| | **Prevent AKI** | Relieve upper tract obstruction; creatinine is already elevated (1.8 mg/dL) | | **Restore bladder compliance** | Overdistended bladder (650 mL) loses contractility if not drained promptly | | **Symptom relief** | Suprapubic pain and distension resolve immediately | | **Diagnostic** | Allows measurement of PVR and assessment of post-void residual | | **Time-sensitive** | Delay >6–12 hours increases risk of permanent detrusor failure | ## Management After Catheterization 1. **Identify and remove precipitant:** Discontinue pseudoephedrine immediately 2. **Optimize medical therapy:** Continue or reinitiate α-blocker (tamsulosin) 3. **Trial of void:** After 24–48 hours, clamp catheter and attempt spontaneous voiding 4. **Definitive treatment:** If trial of void fails, consider TURP or open prostatectomy **Mnemonic:** **CURE** = Catheterize Urgently, Remove offending agent, Evaluate, Re-trial of void ## Why Other Options Are Incorrect - **Option 0 (Discontinue tamsulosin + finasteride):** Addresses the underlying BPH but does **not** manage the acute emergency. The bladder is acutely overdistended with 650 mL urine and rising creatinine — this requires **immediate decompression**, not pharmacotherapy alone. - **Option 1 (TURP):** Definitive surgical treatment is appropriate **only if** the patient fails trial of void after catheterization and medical optimization. TURP is not the immediate management of acute retention; it is reserved for recurrent or refractory cases after conservative measures. - **Option 3 (IV furosemide + observation):** Dangerous and contraindicated. Diuretics will worsen obstruction and increase intravesical pressure, accelerating renal damage. Observation without catheterization risks permanent bladder decompensation and irreversible AKI. [cite:Harrison 21e Ch 297; Campbell-Walsh Urology 12e Ch 102]